Implementation assessment of a patient personalized clinical pharmacy programme (5P project) into orthogeriatric care pathway.
clinical pharmacy
implementation study
orthogeriatric care pathway
Journal
Journal of clinical pharmacy and therapeutics
ISSN: 1365-2710
Titre abrégé: J Clin Pharm Ther
Pays: England
ID NLM: 8704308
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
revised:
19
01
2022
received:
04
01
2022
accepted:
27
01
2022
pubmed:
27
2
2022
medline:
28
7
2022
entrez:
26
2
2022
Statut:
ppublish
Résumé
The orthogeriatric path (hip-fractured elderly patients) is composed of several transition points (emergency surgery, orthopaedic, geriatric and rehabilitation units). The intervention of clinical pharmacists can ensure the continuity of patients' drug management during their hospital stay. The aim of the study was to assess the implementation of clinical pharmacy activities in an orthogeriatric pathway, regarding its impact on medication error prevention, the healthcare professionals' and patients' satisfaction, and the estimated associated pharmaceutical workload. Participants were aged 75 or older and managed for proximal femoral fracture. Their admission prescription was reviewed. If they were evaluated at high risk of adverse event (AE), medication reconciliation (MedRec) and pharmaceutical interviews (admission, discharge, and targeted on oral anticoagulant) were added at different steps of their care pathway. The achievement and duration of each clinical pharmacy activity were recorded. The number of pharmaceutical interventions (PI) made during prescription review, and unintentional discrepancies (UID) identified during MedRec were collected. A satisfaction questionnaire was sent to patients and healthcare professionals. Among 455 included patients, 284 patients were considered at high risk of AE. Clinical pharmacy activity achievement rates varied between 12% and 98%. A total of 622 PI and 333 UID were identified. The overall patients' and healthcare professionals' satisfaction was rated from 63% to 100%. The total workload was estimated at 376 h: on average 16 min per prescription review, 43 min per admission MedRec, 26 min per discharge MedRec and 17 to 25 minutes per interview. The implementation of the programme showed a high potential of drug management securing. To sustain it, additional pharmaceutical human resources and high-performance computing tools are needed.
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
956-963Subventions
Organisme : Ministère des Affaires Sociales et de la Santé
Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Leguelinel-Blache G, Arnaud F, Bouvet S, et al. Impact of admission medication reconciliation performed by clinical pharmacists on medication safety. Eur J Intern Med. 2014;25(9):808-814.
Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547-557.
Xin C, Xia Z, Jiang C, Lin M, Li G. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;11(10):1197-1203.
El Hajji FWD, Scullin C, Scott MG, McElnay JC. Enhanced clinical pharmacy service targeting tools: risk-predictive algorithms. J Eval Clin Pract. 2015;21(2):187-197.
Pérennes M, Carde A, Nicolas X, Dolz M, Bihannic R, Grimont P, et al. [Medication reconciliation: an innovative experience in an internal medicine unit to decrease errors due to inaccurate medication histories]. Presse Medicale Paris Fr 1983. 2012;41(3 Pt 1):e77-86.
Magalhães GF, Santos GBNDC, Rosa MB, Noblat LDACB. Medication reconciliation in patients hospitalized in a cardiology unit. PLoS One. 2014;9(12):e115491. 10.1371/journal.pone.0115491
South East England Specialist Pharmacy Services. Prioritising pharmaceutical care delivery in the acute inpatient setting: a resource for pharmacy managers [Internet]. [cited 2020 Jul 22]. Available from: https://www.sps.nhs.uk/articles/prioritising-pharmaceutical-care-delivery-in-the-acute-inpatient-setting-a-resource-for-pharmacy-managers/
Falconer N, Barras M, Cottrell N. How hospital pharmacists prioritise patients at high-risk for medication harm. Research in Social and Administrative Pharmacy. 2019;15(10):1266-1273. 10.1016/j.sapharm.2018.11.003
Renaudin P, Coste A, Audurier Y, et al. Clinical, economic, and organizational impact of the clinical pharmacist in an orthopedic and trauma surgery department. Journal of Patient Safety. 2021;17(8):e1507-e1513. 10.1097/PTS.0000000000000539
Hyland SJ, Kramer BJ, Fada RA, Lucki MM. Clinical pharmacist service associated with improved outcomes and cost savings in total joint arthroplasty. J Arthroplasty. 2020;35(9):2307-2317.e1.
Kiesel E, Hopf Y. Hospital pharmacists working with geriatric patients in Europe: a systematic literature review. Eur J Hosp Pharm Sci Pract. 2018;25(e1):e74-81.
Gomez M, Marc C, Talha A, et al. Fast track care for pertrochanteric hip fractures: how does it impact length of stay and complications? Orthop Traumatol Surg Res OTSR. 2019;105(5):979-984.
Sinvani LD, Beizer J, Akerman M, et al. Medication reconciliation in continuum of care transitions: a moving target. J Am Med Dir Assoc. 2013;14(9):668-672.
Hoegy D, Martin J, Barral M, Ranchon F, Janoly-Dumenil A, Delande E, et al. Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks. Res Soc Adm Pharm [Internet]. 2021 Aug 8 [cited 2021 Aug 23]; Available from: https://www.sciencedirect.com/science/article/pii/S1551741121002916
Barral M, Martin J, Carre E, et al. How a patient personalised clinical pharmacy programme can secure therapeutic care in an orthogeriatric care pathway (5P Project)? Clin Interv Aging. 2021;21(16):1857-1867.
Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725-731.
Allenet B, Bedouch P, Rose F-X, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci PWS. 2006;28(4):181-188.
WHOCC - Structure and principles [Internet]. [cited 2021 Feb 10]. Available from: https://www.whocc.no/atc/structure_and_principles/
Raimbault-Chupin M, Spiesser-Robelet L, Guir V, et al. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing. Int J Clin Pharm. 2013;35(5):847-853.
Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging. 2016;11:1343-1350.
Neville HL, Chevalier B, Daley C, et al. Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital. Int J Pharm Pract. 2014;22(3):216-222.
Gjerde AM, Aa E, Sund JK, Stenumgard P, Johnsen LG. Medication reconciliation of patients with hip fracture by clinical pharmacists. Eur J Hosp Pharm. 2016;23(3):166-170.
Beckett RD, Crank CW, Wehmeyer A. Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients. J Pharm Pract. 2012;25(2):136-141.
Redmond P, Carroll H, Grimes T, et al. GPs’ and community pharmacists’ opinions on medication management at transitions of care in Ireland. Fam Pract. 2016;33(2):172-178.
Kennelty KA, Chewning B, Wise M, Kind A, Roberts T, Kreling D. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists’ perspectives. Res Soc Adm Pharm RSAP. 2015;11(4):517-530.
Meguerditchian AN, Krotneva S, Reidel K, Huang A, Tamblyn R. Medication reconciliation at admission and discharge: a time and motion study. BMC Health Serv Res. 2013;21(13):485.